Activated STAT-1 pathway in the myocardium as a novel therapeutic target in ischaemia/reperfusion injury.
The signal transducers and activators of transcription (STAT) factors function as modulators of cytokine signaling and sensors responding to UV and ischaemic stress. Recently, we have reported a number of transcriptional mechanisms that induce expression of pro-apoptotic genes following ischaemia/reperfusion (I/R) in cardiac myocytes. For example, we have shown that STAT-1 plays a role in enhancing apoptotic cell death in cardiac myocytes exposed to I/R. In contrast to STAT-1, STAT-3, which is activated by the IL-6 cytokine family, has cardioprotective effects in cardiac myocytes exposed to I/R. The induction of apoptosis in cardiac myocytes by STAT-1 is dependent on STAT-1 phosphorylation on serine-727. Furthermore, we have demonstrated that the C-terminal transactivation domain of STAT-1 is required to mediate apoptotic cell death in cardiac myocytes exposed to I/R. Finally, cardiac myocytes isolated from mice expressing a truncated C-terminal STAT-1 were more sensitive to I/R-induced cell death. The isolated intact hearts from these animals exposed to I/R injury, had larger infarct size and a greater number of TUNEL-positive myocytes than control hearts. Hence, these studies demonstrate that activated STAT-1 is a pro-apoptotic factor in cardiac myocytes exposed to I/R, and is therefore a potential therapeutic target for the prevention of cell death following I/R injury.[1]References
- Activated STAT-1 pathway in the myocardium as a novel therapeutic target in ischaemia/reperfusion injury. Stephanou, A. Eur. Cytokine Netw. (2002) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
